Atlas Trials

Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial

Clinical trial NCT04626973 · COMPLETED

Trial details

NCT number
NCT04626973
Sponsor
Yonsei University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Atherosclerotic Cardiovascular Disease
Start date
2021-01-15
Primary completion
2025-09-24
Enrollment
3048

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.